Overview

Update
Total Equity Funding
$23.52M in 3 Rounds from 2 Investors
Most Recent Funding
$7.72M Series B on September 4, 2013
Headquarters:
Geneva
Description:
Mind-NRG develops peptidic neurotrophic factors for psychiatric and neurologic diseases.
Categories:
Medical Device, Biotechnology, Neuroscience
Website:
http://www.mind-nrg.com

Funding Rounds (3) - $23.52M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2013€6M / Series B2
Jan, 2011$2M / Series A1
Oct, 2010€10M / Series A1

Investors (2)

InvestorRound(s)Partner(s)
Series A (Lead)-
Series A-
Series B-
Series B (Lead)-

News (3)

Update

Offices/Locations (1)

Update
  • Office

    Rue de Jargonnant 2

    Geneva, CH-1207

    CHE

Images (1)

Update

Add Acquisitions

Add Current Team

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos